Publications by authors named "Steven Pavletic"

100Publications

CD69+ resident memory T cells are associated with graft-versus-host disease in intestinal transplantation.

Am J Transplant 2020 Nov 23. Epub 2020 Nov 23.

MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital and the Center for Translational Transplant Medicine, Georgetown University Medical Center, 3800 Reservoir Road NW, Washington, DC, 20007.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajt.16405DOI Listing
November 2020

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation.

Front Immunol 2020 25;11:2017. Epub 2020 Aug 25.

Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2020.02017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479824PMC
August 2020

A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703.

Biol Blood Marrow Transplant 2020 Dec 10;26(12):e305-e308. Epub 2020 Sep 10.

Department of Hematology/Oncology, Mayo Clinic College of Medicine, Phoenix, Arizona. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.08.029DOI Listing
December 2020

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

Biol Blood Marrow Transplant 2020 Aug 17;26(8):1459-1468. Epub 2020 May 17.

Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391266PMC
August 2020

Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host Disease.

JAMA Dermatol 2020 Jul;156(7):814-817

Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2020.1157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344382PMC
July 2020

Quality of Life in Patients With Skin of Color and Chronic Graft-vs-Host Disease.

JAMA Dermatol 2020 May;156(5):589-590

Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2019.4857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042814PMC
May 2020

Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.

Support Care Cancer 2020 Aug 6;28(8):3679-3689. Epub 2019 Dec 6.

Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, MSC 1604, 10 Center Drive, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-05207-zDOI Listing
August 2020

Oral Complications of Chronic Graft-Versus-Host Disease.

J Natl Cancer Inst Monogr 2019 08;2019(53)

Department of Oral Medicine, University of Washington, School of Dentistry and Seattle Cancer Care Alliance and Oral Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgz007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699578PMC
August 2019

Accompanying editorial on paper Neutrophil extracellular traps (NETs) contribute to Pathological Changes of ocular graft-vs.-Host Disease (oGVHD) dry eye: Implications for novel Biomarkers and Therapeutic Strategies by Seungwon An et al.

Ocul Surf 2019 07 19;17(3):372-373. Epub 2019 Jun 19.

National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtos.2019.06.006DOI Listing
July 2019

Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus.

Mayo Clin Proc Innov Qual Outcomes 2017 Sep 2;1(2):198-201. Epub 2017 Aug 2.

Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25424548173003
Publisher Site
http://dx.doi.org/10.1016/j.mayocpiqo.2017.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134909PMC
September 2017

Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally.

Bone Marrow Transplant 2019 03 23;54(3):383-392. Epub 2018 Jul 23.

Division of Hematology and Stem Cell Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0266-6DOI Listing
March 2019

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

J Clin Oncol 2018 08 29;36(22):2267-2280. Epub 2018 May 29.

Jennifer N. Brudno, Irina Maric, Steven D. Hartman, Jeremy J. Rose, Norris Lam, Maryalice Stetler-Stevenson, Dalia Salem, Constance Yuan, Steven Pavletic, Jennifer A. Kanakry, Lekha Mikkilineni, Steven A. Feldman, David F. Stroncek, Brenna G. Hansen, Rashmika Patel, Frances Hakim, Ronald E. Gress, and James N. Kochenderfer, National Institutes of Health, Bethesda; Syed Abbas Ali, Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore; Judith Lawrence, Leidos Biomedical Research, Frederick, MD; Michael Wang, University of Texas MD Anderson Cancer Center, Houston, TX; and Dalia Salem, Mansoura University, Mansoura, Egypt.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.77.8084
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.77.8084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067798PMC
August 2018

Introduction to a review series on emerging immunotherapies for hematologic diseases.

Blood 2018 06 4;131(24):2617-2620. Epub 2018 May 4.

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-840793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032896PMC
June 2018

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.

Biol Blood Marrow Transplant 2018 09 14;24(9):1920-1927. Epub 2018 Mar 14.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.03.008DOI Listing
September 2018

Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2018 07 1;24(7):1415-1423. Epub 2018 Mar 1.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.02.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045967PMC
July 2018

Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.

Biol Blood Marrow Transplant 2017 Nov 7;23(11):1980-1988. Epub 2017 Aug 7.

Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786784PMC
November 2017

Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease.

Am J Hematol 2017 Aug 1;92(8):E162-E164. Epub 2017 Jun 1.

Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24768DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551423PMC
August 2017

Immunotherapy in hematologic malignancies: past, present, and future.

J Hematol Oncol 2017 04 24;10(1):94. Epub 2017 Apr 24.

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://jhoonline.biomedcentral.com/articles/10.1186/s13045-0
Publisher Site
http://dx.doi.org/10.1186/s13045-017-0453-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402171PMC
April 2017

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

Biol Blood Marrow Transplant 2017 01 29;23(1):6-9. Epub 2016 Oct 29.

Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.10.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182086PMC
January 2017

Early Diagnosis of Labial Fusion in Women After Allogeneic Hematopoietic Cell Transplant Enables Outpatient Treatment.

J Low Genit Tract Dis 2017 Apr;21(2):157-160

1Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD; 2Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; 3Intramural Office of Rare Diseases, Office of the Director, National Institutes of Health, Bethesda, MD; 4Community Health Center Zagreb East, Department of Gynecology, Zagreb, Croatia; 5Graft-versus-Host and Autoimmunity Unit, Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; 6Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD; and 7Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LGT.0000000000000288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365355PMC
April 2017

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Biol Blood Marrow Transplant 2017 Mar 12;23(3):367-378. Epub 2016 Sep 12.

National Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285307PMC
March 2017

Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.

Croat Med J 2016 Jun;57(3):266-75

Tamara Vukić, Department of Rehabilitation and Orthopeadic Aids, University Hospital Center Zagreb, Božidarevićeva 11, 10000 Zagreb, Croatia,

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937232PMC
http://dx.doi.org/10.3325/cmj.2016.57.266DOI Listing
June 2016

Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?

Croat Med J 2016 Jun;57(3):239-46

Nadira Duraković, University Hospital Centre Zagreb, Dept of Internal Medicine, Division of Hematology, Kišpatićeva 12, 10000 Zagreb, Croatia,

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937225PMC
http://dx.doi.org/10.3325/cmj.2016.57.239DOI Listing
June 2016

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

J Clin Oncol 2016 06 4;34(16):1864-71. Epub 2016 Apr 4.

Brian C. Shaffer and Martin Tallman, Memorial Sloan Kettering Cancer Center; Adriana K. Malone, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai; Ran Reshef, Columbia University Medical Center, New York; Mark Litzow, Mayo Clinic Rochester; Jane Liesveld, University of Rochester Medical Center, Rochester; Peter H. Wiernik, Our Lady of Mercy Medical Center, Bronx, NY; Kwang Woo Ahn, Zhen-Huan Hu, and Wael Saber, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Taiga Nishihori and Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David Valcárcel, Hospital Vall d'Hebron, Barcelona, Spain; Michael R. Grunwald, Omotayo Fasan, and Edward Copelan, Levine Cancer Institute, Carolinas HealthCare System, Charlotte; William Allen Wood, University of North Carolina at Chapel Hill, Chapel Hill; David A. Rizzieri, Duke University Medical Center, Durham, NC; Ulrike Bacher, University of Medicine Göttingen, Göttingen, Germany; Betty Hamilton and Aaron Gerds, Cleveland Clinic Taussig Cancer Institute; Matt Kalaycio and Ron Sobecks, Cleveland Clinic Foundation, Cleveland; Basem William, Ohio State University Medical Center, Columbus, OH; Ayman Saad and Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Corey Cutler and Edwin Alyea, Dana-Farber Cancer Institute, Boston, MA; Erica Warlick and Celalettin Ustun, University of Minnesota Medical Center, Minneapolis, MN; Baldeep Mona Wirk, Seattle Cancer Care Alliance, Seattle, WA; Mitchell Sabloff, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario; Andrew Daly, Tom Baker Cancer Center, Calgary, Alberta, Canada; David Marks, University Hospitals Bristol National Health Service Trust, Bristol; Robert Peter Gale, Imperial College London, London, United Kingdom; Richard Olsson, Karolinska Institutet, Stockholm, Sweden; Alan M. Miller, Baylor University Medical Center; Rammurti Kamble

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966345PMC
June 2016

Chronic graft-vs-host disease in 2016: a major challenge and an opportunity.

Croat Med J 2016 Feb;57(1):1-3

Dražen Pulanić, Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia,

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800321PMC
http://dx.doi.org/10.3325/cmj.2016.57.1DOI Listing
February 2016

Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Biochim Biophys Acta 2016 Aug 26;1860(8):1615-22. Epub 2016 Feb 26.

Graft-versus-Host and Autoimmunity Section, Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagen.2016.02.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907829PMC
August 2016

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

J Clin Oncol 2016 Apr 25;34(10):1112-21. Epub 2016 Jan 25.

Jennifer N. Brudno, Robert P.T. Somerville, Victoria Shi, Jeremy J. Rose, David C. Halverson, Daniel H. Fowler, Juan C. Gea-Banacloche, Steven Z. Pavletic, Dennis D. Hickstein, Tangying L. Lu, Steven A. Feldman, Alexander T. Iwamoto, Brenna G. Hansen, Bazetta Blacklock-Schuver, Frances T. Hakim, Steven A. Rosenberg, Ronald E. Gress, and James N. Kochenderfer, National Cancer Institute; Roger Kurlander and Irina Maric, National Institutes of Health, Bethesda; Jennifer S. Wilder, Frederick National Laboratory for Cancer Research, Frederick, MD; and Andre Goy, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872017PMC
April 2016

Deciphering the Mystery: Extracorporeal Photopheresis in Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2015 Nov 18;21(11):1861-2. Epub 2015 Sep 18.

National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786786PMC
November 2015

Immunotherapy for acute leukemia.

Aging (Albany NY) 2015 Jun;7(6):354-5

National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505159PMC
http://dx.doi.org/10.18632/aging.100768DOI Listing
June 2015

Extracorporeal photopheresis as a therapy for autoimmune diseases.

J Clin Apher 2015 Aug 26;30(4):224-37. Epub 2014 Dec 26.

Graft-versus-Host and Autoimmunity Unit, Experimental Transplantation and Immunology Branch, National Cancer Institute NCI, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.21367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786791PMC
August 2015

Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.

Am J Hematol 2015 Feb 24;90(2):114-9. Epub 2014 Nov 24.

Graft-versus-Host and Autoimmunity Unit, Experimental Transplantation and Immunology Branch, National Cancer Institute NCI, National Institutes of Health, Bethesda, Maryland; Internal Medicine Department, Evangelical Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23885DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535796PMC
February 2015

Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.

JAMA Dermatol 2015 Jan;151(1):23-32

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2014.1550DOI Listing
January 2015

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Sep 9;20(9):1341-8. Epub 2014 May 9.

Division of Bone Marrow Transplantation, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127362PMC
September 2014

Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.

Transfusion 2014 Apr 10;54(4):1088-92. Epub 2013 Oct 10.

Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983171PMC
April 2014

Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2013 Oct 13;19(10):1509-13. Epub 2013 Aug 13.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511977PMC
October 2013

Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.

Exp Hematol 2013 Sep 18;41(9):772-8. Epub 2013 May 18.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769491PMC
September 2013